title: Global tuberculosis control: lessons learnt and future prospects.
abstract: Tuberculosis (TB) is an ancient disease, but not a disease of the past. After disappearing from the world public health agenda in the 1960s and 1970s, TB returned in the early 1990s for several reasons, including the emergence of the HIV/AIDS pandemic and increases in drug resistance. More than 100 years after the discovery of the tubercle bacillus by Robert Koch, what is the status of TB control worldwide? Here, we review the evolution of global TB control policies, including DOTS (directly observed therapy, short course) and the Stop TB Strategy, and assess whether the challenges and obstacles faced by the public health community worldwide in developing and implementing this strategy can aid future action towards the elimination of TB.
authors.affiliation: Stop TB Department, World Health Organization, Desk D4 6017, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. ienhardtc@who.int
authors.forename: Christian
authors.initials: C
authors.lastname: Lienhardt
authors.forename: Philippe
authors.initials: P
authors.lastname: Glaziou
authors.forename: Mukund
authors.initials: M
authors.lastname: Uplekar
authors.forename: Knut
authors.initials: K
authors.lastname: Lönnroth
authors.forename: Haileyesus
authors.initials: H
authors.lastname: Getahun
authors.forename: Mario
authors.initials: M
authors.lastname: Raviglione
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000494:pharmacology; D003140:Communicable Disease Control / Q000379:methods*; D021821:Communicable Diseases, Emerging / Q000453:epidemiology* / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D004358:Drug Therapy / Q000379:methods; D014943:Global Health; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D000995:Antitubercular Agents